India, May 11 -- WORK Medical Technology Group Ltd. (WOK), a supplier of medical devices in China, announced it has entered into a strategic cooperation agreement with Shanghai Novabioplus Biotechnology Co., Ltd. to jointly develop next-generation intelligent medical models.
The collaboration, signed on April 13, 2026, aims to integrate WORK Medical's AI expertise with Novabioplus' extensive protein data resources to unlock the latent value of biological data assets.
The partnership will focus on four major "AI+" projects: AI-based membrane protein design, antibody sequence optimization, enzyme molecule design, and peptide design. These initiatives combine advanced data governance with model training to enable precise biomolecular design ...